Els Plettinckx1, Forrest W Crawford2, Jérôme Antoine3, Lies Gremeaux3, Luk Van Baelen3. 1. Directorate of Epidemiology and Public Health, Sciensano, Rue Juliette Wytsmanstraat, 14, 1050 Brussels, Belgium. Electronic address: els.plettinckx@sciensano.be. 2. Department of Biostatistics, Yale School of Public Health, 60 College Street, New Haven, CT 06520-0834, United States. 3. Directorate of Epidemiology and Public Health, Sciensano, Rue Juliette Wytsmanstraat, 14, 1050 Brussels, Belgium.
Abstract
BACKGROUND: For Belgium, available estimates of the number of people who inject drugs (PWID) are based on data from more than fifteen years ago and apply only to those who report ever injecting drugs. As a result, no reliable baseline data exist to determine the scale of services for PWID. METHODS: We obtained pseudo-anonymized identifier information from treatment and harm reduction service providers and a fieldwork study between February and April 2019 in Brussels. We estimated the number of PWID, defined as people who injected within the last 12 months, in Brussels using capture-recapture (CRC) methodology. To obtain national estimates, we scaled the proportion of PWID in Brussels to the total number of this population in Belgium based on two existing drug treatment registers, which were then multiplied with the result of the CRC. RESULTS: The total population of PWID is estimated to be 703 (95 %CI 538-935) for Brussels and between 6620 (95 %CI 4711 - 8576) and 7018 (95 %CI 4794 - 9527) for Belgium. CONCLUSIONS: These estimates provide crucial information to ensure that services to PWID are adequately maintained. They clearly indicate the need to maximize efforts to achieve the targets set by WHO for 2030 on the provision of 300 sterile needles and syringes per PWID per year, a 90 % reduction of new HCV infections, and a 65 % reduction of liver-related mortality.
BACKGROUND: For Belgium, available estimates of the number of people who inject drugs (PWID) are based on data from more than fifteen years ago and apply only to those who report ever injecting drugs. As a result, no reliable baseline data exist to determine the scale of services for PWID. METHODS: We obtained pseudo-anonymized identifier information from treatment and harm reduction service providers and a fieldwork study between February and April 2019 in Brussels. We estimated the number of PWID, defined as people who injected within the last 12 months, in Brussels using capture-recapture (CRC) methodology. To obtain national estimates, we scaled the proportion of PWID in Brussels to the total number of this population in Belgium based on two existing drug treatment registers, which were then multiplied with the result of the CRC. RESULTS: The total population of PWID is estimated to be 703 (95 %CI 538-935) for Brussels and between 6620 (95 %CI 4711 - 8576) and 7018 (95 %CI 4794 - 9527) for Belgium. CONCLUSIONS: These estimates provide crucial information to ensure that services to PWID are adequately maintained. They clearly indicate the need to maximize efforts to achieve the targets set by WHO for 2030 on the provision of 300 sterile needles and syringes per PWID per year, a 90 % reduction of new HCV infections, and a 65 % reduction of liver-related mortality.
Authors: Jisoo A Kwon; Jenny Iversen; Matthew Law; Kate Dolan; Handan Wand; Lisa Maher Journal: Drug Alcohol Depend Date: 2019-02-13 Impact factor: 4.492
Authors: Harry Levine; Tyler S Bartholomew; Victoria Rea-Wilson; Jason Onugha; David Jonathon Arriola; Gabriel Cardenas; David W Forrest; Alex H Kral; Lisa R Metsch; Emma Spencer; Hansel Tookes Journal: Drug Alcohol Depend Date: 2019-06-29 Impact factor: 4.492
Authors: Hannah Fraser; Natasha K Martin; Henrikki Brummer-Korvenkontio; Patrizia Carrieri; Olav Dalgard; John Dillon; David Goldberg; Sharon Hutchinson; Marie Jauffret-Roustide; Martin Kåberg; Amy A Matser; Mojca Matičič; Havard Midgard; Viktor Mravcik; Anne Øvrehus; Maria Prins; Jens Reimer; Geert Robaeys; Bernd Schulte; Daniela K van Santen; Ruth Zimmermann; Peter Vickerman; Matthew Hickman Journal: J Hepatol Date: 2018-01-08 Impact factor: 25.083
Authors: Lucy Platt; Martin Wall; Tim Rhodes; Ali Judd; Matthew Hickman; Lisa G Johnston; Adrian Renton; Natalia Bobrova; Anya Sarang Journal: J Urban Health Date: 2006-11 Impact factor: 3.671
Authors: Sarah Larney; Matthew Hickman; Rebecca Guy; Jason Grebely; Gregory J Dore; Richard T Gray; Carolyn A Day; Jo Kimber; Louisa Degenhardt Journal: BMC Public Health Date: 2017-09-29 Impact factor: 3.295